CIP
ARNA

Chartwell Investment Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Chartwell Investment Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,231
Closed -$1.44M – 455
2021
Q3 		$1.44M Buy
24,231
+4,588
+23% +$271K 0.04% 339
2021
Q2 		$1.34M Buy
19,643
+187
+1% +$12.2K 0.04% 345
2021
Q1 		$1.35M Sell
19,456
-1,045
-5% -$80.4K 0.04% 338
2020
Q4 		$1.57M Sell
20,501
-4,644
-18% -$348K 0.05% 314
2020
Q3 		$1.88M Hold
25,145
– – 0.07% 283
2020
Q2 		$1.58M Sell
25,145
-9,169
-27% -$504K 0.06% 287
2020
Q1 		$1.44M Buy
34,314
+3,951
+13% +$181K 0.07% 285
2019
Q4 		$1.38M Sell
30,363
-29,774
-50% -$1.41M 0.05% 331
2019
Q3 		$2.75M Hold
60,137
– – 0.09% 274
2019
Q2 		$3.53M Buy
60,137
+3,604
+6% +$186K 0.12% 251
2019
Q1 		$2.53M Buy
56,533
+766
+1% +$35.1K 0.08% 299
2018
Q4 		$2.17M Sell
55,767
-26,072
-32% -$1.02M 0.08% 321
2018
Q3 		$3.77M Buy
81,839
+114
+0.1% +$4.62K 0.11% 269
2018
Q2 		$3.56M Sell
81,725
-3,245
-4% -$139K 0.11% 259
2018
Q1 		$3.36M Buy
+84,970
New +$3.31M 0.11% 228

Other funds holding ARNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Chartwell Investment Partners's ARNA Position: Q4 2021 in Review

Chartwell Investment Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 24,231 shares — an estimated $1.44M sold.

Chartwell Investment Partners first reported a position in ARNA in Q1 2018 and held it in 15 quarters. The position peaked at $3.77M in Q3 2018. 316 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

  • Chartwell Investment Partners reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
  • Chartwell Investment Partners sold 24,231 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $1.44M.
  • Chartwell Investment Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 15 quarters.
  • Chartwell Investment Partners's Arena Pharmaceuticals Inc position peaked at $3.77M in Q3 2018.
  • 316 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Chartwell Investment Partners's 13F filing for Q4 2021, filed 15 Feb 2022.